Steroid Profiling in Urine of Intact Glucuronidated and Sulfated

Total Page:16

File Type:pdf, Size:1020Kb

Steroid Profiling in Urine of Intact Glucuronidated and Sulfated CORE Metadata, citation and similar papers at core.ac.uk Provided by Ghent University Academic Bibliography Journal of Chromatography A 1624 (2020) 461231 Contents lists available at ScienceDirect Journal of Chromatography A journal homepage: www.elsevier.com/locate/chroma Steroid profiling in urine of intact glucuronidated and sulfated steroids using liquid chromatography-mass spectrometry ∗ Laurie De Wilde , Kris Roels, Pieter Van Renterghem, Peter Van Eenoo, Koen Deventer 1 Doping Control Laboratory (DoCoLab), Ghent University (UGent), Department Diagnostic Sciences, Technologiepark 30B, B-9052 Zwijnaarde, Belgium a r t i c l e i n f o a b s t r a c t Article history: Detection of endogenous anabolic androgenic steroids (EAAS) misuse is a major challenge in doping con- Received 26 November 2019 trol analysis. Currently, a number of endogenous steroids, which constitute the steroid profile, are quanti- Revised 6 May 2020 fied using gas chromatography (GC). With this methodology, only the sum of the free and glucuronidated Accepted 10 May 2020 steroids is measured together. A dilute-and-shoot LC-MS method, which is compliant with the quality Available online 23 May 2020 requirements for measuring EAAS established by the World Anti-Doping Agency (WADA), was devel- Keywords: oped and validated containing glucuronidated and sulfated steroids in order to gain some extra infor- Doping mation and to expand the existing steroid profile. The developed method is, to the best of our knowl- Urine edge, the first method to combine both steroid glucuronides and sulfates, which is compliant with the Steroid profile quality standards of the technical document on EAAS, established by WADA. The first advantage of this Intact conjugates new steroid profile is the reduced sample preparation time, as it is a direct injection method of diluted Dilute-and-shoot urine. A second advantage is the ability of the used gradient to separate 5 α-androstane-3 α,17 β-diol- 3-glucuronide (5 ααβdiol3G), 5 α-androstane-3 α,17 β-diol-17-glucuronide (5 ααβdiol17G), 5 β-androstane- 3 α,17 β-diol-3-glucuronide (5 βαβdiol3G) and 5 β-androstane-3 α,17 β-diol-17-glucuronide (5 βαβdiol17G) allowing to gain specific information on these isomers, which cannot be accomplished in GC-MS screen- ing due to hydrolysis. This steroid profile also contains free testosterone, 5 α-androstane-3,17-dione and 5 β-androstane-3,17-dione as markers of degradation. In total, 17 compounds and 10 isotopically labelled internal standards are included in this method. © 2020 Elsevier B.V. All rights reserved. 1. Introduction trations of EAAS, which makes population limits insufficient to confirm whether an elevated concentration is a result of steroid Endogenous anabolic androgenic steroids (EAAS) are substances abuse. To circumvent this problem, the athlete’s steroidal pass- produced in the human body and are related to the metabolic port was introduced, as a part of the athlete’s biological pass- pathways of testosterone. In the clinical field, the measurement of port (ABP), which contains basal concentrations of EAAS and ra- steroids is very important for therapeutic drug monitoring, the di- tios among them, with the testosterone/epitestosterone ratio (T/E) agnosis and monitoring of endocrine disorders and cancers (e.g., as the most important marker [ 8 , 9 , 11 , 16–21 ]. By using the adaptive breast, prostate and endometrium). Highly sensitive and specific model, individual reference limits can be established which allow methods are needed for an accurate diagnosis and the measure- the comparison of a measured value with results from previous ment of low concentrations of steroids. The most common matri- tests [ 8 , 9 , 11 , 16–19 , 21 ]. When suspicious results are found, a con- ces for steroid analysis are serum, plasma, urine and saliva [1–4] . firmation by gas chromatography-combustion-isotope ratio mass As the use of EAAS can enhance sports performances, it is pro- spectrometry (GC-C-IRMS) is performed to confirm the endoge- hibited by the World Anti-doping Agency (WADA) [5] . An abuse nous or exogenous origin of the steroids [ 9 , 11 , 13 , 15–17 , 19 , 20 , 22 ], with this class of doping substances is difficult to track down be- although eventually the ABP could also by itself be used to prose- cause these steroids are also formed endogenously [6–19] . Fur- cute a doping infraction. thermore, there is a large inter-individual variation in concen- The extensive metabolism of EAAS is divided into two phases. In phase I, oxidations and reductions occur to inactivate the com- pound and to facilitate its elimination. In phase II, the steroid is ∗ Corresponding author. coupled to glucuronic acid or a sulfate group by conjugation re- E-mail address: [email protected] (L. De Wilde). actions, making the steroid more polar, which also facilitates its 1 Doping Control Laboratory (DoCoLab), Ghent University, Department Diagnostic urinary excretion [ 7–9 , 14 , 15 , 17 , 22–27 ]. For example, 3 α-hydroxy Sciences, Technologiepark 30 B, B-9052 Zwijnaarde, Belgium. https://doi.org/10.1016/j.chroma.2020.461231 0021-9673/© 2020 Elsevier B.V. All rights reserved. 2 L. De Wilde, K. Roels and P. Van Renterghem et al. / Journal of Chromatography A 1624 (2020) 461231 steroids are conjugated with glucuronic acid, while 3 β-hydroxy androsterone sulfate, androsterone sulfate-d4 (AS-d4), epitestos- steroids are conjugated as sulfates [ 7 , 17 , 28 ]. Glucuronidation and terone glucuronide (EG), epitestosterone glucuronide-d3 (EG-d3), sulfatation at the 17 β-hydroxy group are well known for testos- epitestosterone sulfate (ES), epitestosterone sulfate-d3 (ES-d3), terone. The major metabolites of AAS are glucuronidated, however etiocholanolone glucuronide (EtioG), etiocholanolone sulfate, some EAAS are also excreted as sulfates [ 7 , 14–18 , 22 , 25 ]. etiocholanolone sulfate-d5 (EtioS-d5), testosterone-d3 (T-d3), In the current steroid profile, constituted by concentrations of testosterone glucuronide (TG), testosterone glucuronide-d3 (TG- EAAS and ratios among them, only glucuronidated steroids are in- d3), testosterone sulfate (TS) and testosterone sulfate-d3 (TS-d3) cluded, as T is mainly conjugated by UGT2B17 and mainly excreted were bought from NMI (Pymble, Australia). 5 α-androstane- in a glucuronidated form [ 11 , 13 , 16–18 , 20 , 22 , 24 , 29 ]. Hence, conven- 3,17-dione was purchased from Steraloids (Newport, R. I.), 5 β- tional sample preparation methods include an enzymatic hydrol- androstane-3,17-dione and testosterone from Sigma-Aldrich ysis step to release the aglycones, whereby information on the (Bornem, Belgium). Dehydroepiandrosterone sulfate (DHEAS) and free or sulfoconjugated fraction is lost. Subsequently, the samples dehydroepiandrosterone sulfate-d5 (DHEAS-d5) were bought from are preconcentrated and analysed by GC-MS after derivatisation Cerilliant (Round Rock, Texas). Epiandrosterone sulfate (EpiAS) was [ 8 , 9 , 13 , 15–18 , 20 , 22–25 , 27 ]. These steps can be time-consuming purchased from TRC (Toronto, Canada). and a source of variation, technical errors and inaccuracy [ 17 , 21 ]. As some people have a decreased glucuronidation of steroids, 2.2. Instruments and consequently a lower T/E because of a deletion/deletion (del/del) polymorphism in UGT2B17, it would be interesting to ex- The LC-MS/MS system consists of a Thermo Scientific Ultimate pand the steroid profile, to gain some information on free steroids 30 0 0, with a heated column compartment thermostated at 55 °C and to include the sulfoconjugated steroids [ 8 , 9 , 11 , 16 , 18 , 19 , 24 , 28 ]. and an XRS open autosampler, connected to a TSQ Vantage (both Previously, the group of Dehennin et al. suggested the ratio be- from Thermo Fisher Scientific). The separation of the compounds tween TG and the sum of EG and ES [ 9 , 28 ] and the ratio be- was performed on a Zorbax Eclipse Plus (C18 2.1 × 100 mm; 1.8 tween EG and ES [9] to distinguish between a physiologically and μm, Agilent Technologies). a pharmacologically high T/E, which was contradicted by the work of Borts et al. [27] . Another advantage of the addition of sulfate 2.2.1. LC gradient conjugates is the improvement of detection windows [ 11 , 19 , 24 , 30 ]. The mobile phases consisted of (A) water and (B) methanol Previous studies have shown the usefulness of epiandrosterone sul- both containing 0.01 % HCOOH/5 mM NH OOCH. A gradient elu- fate (EpiAS), which is known to be only excreted as a sulfoconju- 4 tion program started with 0 % B for 0.1 min after which it was gate [ 19 , 31–33 ]. Androsterone sulfate (AS) and etiocholanolone sul- immediately increased to 35 %. After 1 min of 35 % B, the gradient fate (EtioS) were also highlighted as promising markers after oral was further increased to 45 % B in 5 min, where it was kept for 5 testosterone undecanoate intake [ 8 , 9 ]. min and was then increased to 50 % in 19 min. For 4.5 min, the Unfortunately, inclusion of the sulfoconjugated steroids into the gradient increased to 90 % B, after which it increased to 100 % in existing GC-MS methods is difficult to achieve due to hydrolysis 0.5 min. This condition was kept for 2 min. The gradient decreased and extraction problems [ 6 , 22–24 , 27 ]. Additionally, hydrolysis of to starting conditions in 0.1 min and was kept for 0.9 min. the sulfonjugates yields the same aglycones as glucuronides and information on the phase II metabolites is lost. Previously, LC-MS has proven to be the ideal technique to anal- 2.2.2. MS parameters yse phase II metabolites of EAAS without the need to hydrolyse Detection of the steroids was carried out by electrospray ion- [ 6 , 8 , 9 , 11 , 12 , 14 , 15 , 18–20 , 23 , 25 , 27 , 34 ]. Some research groups anal- ization (ESI) in the selective reaction mode (SRM) and tuned S- ysed intact glucuronides [12] , intact sulfates [ 6 , 11 , 19 ] or a com- lens values were used.
Recommended publications
  • Test Report Comprehensive Hormone Insights™
    698814 COMPREHENSIVE HORMONE INSIGHTS™ TEST REPORT Dr. Maximus, N.D. E: [email protected] Date of Collection: P: 403-241-4500 Time of Collection: F: 403-241-4501 Date of Receipt: www.rmalab.com Reported On: CHI Accession: 698814 Healthcare Professional Patient Age: Dr. Maximus, N.D. Date of Birth: Gender: Male F: Relevant Medications Biometrics Curcumin Height (in) : 73 Weight (lb) : 180 BMI : 24 Waist (in) : 35 Hip (in) : 41 CHI Accession: 698814 SUMMARY HMUS01 How to read the graphs LEGEND: 50 66 Sex Steroid Hormones 50 66 Middle third of 33 33 84 reference population Hormone Start of 83 100 80 100 highest 16 Percentile Precursors 16 Percentile third of Sum of Androgens Sum of Estrogens 50 66 reference 0 0 population (T, DHT, α+β androstanediol) Listed in Interp Guide 33 84 End of 100 16 lowest Percentile00 50 66 50 66 third of 33 33 84 reference 0 population Patient’s percentile rank 81 100 95 100 compared to reference 16 Percentile 16 Percentile population (see summary) DHEA + Metabolites Sum of Progesterone Metabolites 0 (DHEA + A + E) 0 α+β Pregnanediol Cortisol Melatonin Oxidative Stress Free Cortisol Profile (ng/mg) 100 50 66 50 66 33 84 33 84 80 64 100 0 100 16 Percentile 16 Percentile 60 6-sulfatoxy 8-Hydroxy-2- 0 Melatonin 0 deoxyguanosine 40 (Overnight) (Overnight) 20 6-sulfatoxymelatonin provides 8-hydroxy-2-deoxyguanosine is Cortisol/Creatinine (ng/mg) insight into melatonin levels. a marker of oxidative stress 0 Morning Dinner Bedtime A B C 50 66 Free cortisol Cortisol Metabolites 33 84 profile is used to provides a general Testosterone Cortisol assess diurnal assessment of 16 100 cortisol rhythm adrenal cortisol 16 Percentile Cortisol production Cortisol Metabolites 0 (α+β THF + THE) Testosterone Cortisol/Testosterone provides insight into relative catabolic (cortisol) and anabolic (testosterone) states.
    [Show full text]
  • Normal Steroid Levels in Racehorses (Print) Page 1 of 2
    The Horse | Normal Steroid Levels in Racehorses (print) Page 1 of 2 Normal Steroid Levels in Racehorses by: Christy West February 28 2010 Article # 15889 Steroid usage in racehorses has received a good deal of attention in the media, perhaps reaching a peak during the 2009 Triple Crown season when Big Brown won the Kentucky Derby and Preakness on the legally administered steroid stanozolol, then flopped in the Belmont without it. While no one could ever prove the steroid helped the horse win or that his loss was associated with being steroid-free, the situation added significant fuel to the fire of medication regulation in racehorses. One of the tough aspects of regulating substances that are naturally produced in the horse's body, such as many steroids, is that before you can decide how high a level of the substance constitutes an administered medication or abuse, you have to find out how much horses produce normally. At the 2009 American Association of Equine Practitioners (AAEP) Convention held Dec. 5-9 in Las Vegas, Nev., one presenter discussed a study that sought to answer that question for anabolic androgenic steroids (hormones that stimulate masculine physical characteristics) in young Thoroughbreds. Currently there are four anabolic androgenic steroids commonly used therapeutically in racehorses: Stanozolol, nandrolone, testosterone, and boldenone, said presenter Benjamin C. Moeller, BS, a graduate student at the K.L. Maddy Equine Analytical Chemistry Laboratory at the University of California, Davis. In collaboration with veterinarians at Rood & Riddle Equine Hospital and Hagyard Equine Medical Institute (both in Lexington, Ky.), and Craig Van Balen (private practitioner in Lexington), 142 un-medicated Thoroughbred colts and 62 fillies in training at Central Kentucky farms, from five to 24 months of age, were blood tested monthly for 13 months.
    [Show full text]
  • Genetics of Androgen Disposition
    From the Department of Laboratory Medicine Division of Clinical Pharmacology Karolinska Institutet, Stockholm, Sweden GENETICS OF ANDROGEN DISPOSITION - Implications for Doping Tests Jenny Jakobsson Schulze Stockholm 2007 All previously published papers were reproduced with permission from the publisher. Published by Karolinska Institutet. © Jenny Jakobsson Schulze, 2007 ISBN 978-91-7357-397-9 Printed by 2007 Gårdsvägen 4, 169 70 Solna One must sit down before truth without preconception, like a little child, and follow where the facts lead- or one will learn nothing. Thomas Huxley (1825-1895) To Joe and Dante ABSTRACT Anabolic androgenic steroids (AAS) are derivatives of testosterone. Doping with AAS is a severe challenge to the vision, moral and ethics in sports and has also become an increasing problem in society. Testosterone abuse is conventionally assessed by the urinary testosterone glucuronide/ epitestosterone glucuronide (T/E) ratio, levels above 4.0 being considered suspicious. However, there is a large inter-individual variation in testosterone glucuronide and epitestosterone glucuronide excretion, which challenges the accuracy of the test. There are reasons to believe that genetic variation is the single most important cause of variation in disposition of many androgenic compounds. Twin studies in men have demonstrated heritability estimates of 85% and 96% for production rates of testosterone and dihydrotestosterone, respectively. The primary aim of this thesis was to investigate the contribution of genetic components to inter-individual variation in androgen disposition. We found that a deletion polymorphism in the UGT2B17 gene was strongly associated with the urinary testosterone glucuronide levels. All individuals homozygous for the deletion had negligible amounts of urinary testosterone glucuronide.
    [Show full text]
  • Development and Application of Methods for Extraction and LC/MS/MS Analysis of Sex Steroids and Conjugates from Fish Feces
    Development and Application of Methods for Extraction and LC/MS/MS Analysis of Sex Steroids and Conjugates from Fish Feces By Lisa E. Peters A Thesis submitted to the Faculty of Graduate Studies of The University of Manitoba in partial fulfilment of the requirements of the degree of Doctor of Philosophy Department of Environment and Geography University of Manitoba Winnipeg Copyright © 2014 Lisa E. Peters 1 Acknowledgments I would like to start by thanking my supervisor, Dr. Gregg Tomy, for his support, patience and resources during my Ph.D. program. He took a chance when I tried to convince him that my biology background would be a great addition to his chemistry lab. My husband, Vince Palace, and I also appreciated his support and genuine happiness for us when I announced we were expecting a baby in the middle of my studies. A sincere thanks also goes to my co-supervisor, Dr. Mark Hanson, for his support on so many levels (I wouldn’t even know where to start), and for doing his best to keep me on track, which was no small task. I would also like to thank my other thesis committee members, Drs. Gary Anderson and Feiyue Wang, for their encouragement and insightful comments. Gary gave a lot of extra time to review various thesis chapters and data, and to lend his expertise during the fish surgeries. I also had the pleasure of taking his Endocrinology course, which was probably the most informative and enjoyable class of my entire university student career. I would like to thank the technical staff and students from DFO, Suzanne Mittermuller, Kerry Wautier, Alea Goodmanson, Danielle Godard, Lisa Friedrich and Kirstin Dangerfield, and my lab mates Bruno Rosenberg, Kerri Pleskach, Colin Darling, Bonnie Gemmill and Lianna Bestvater for their technical input and help during my experiments.
    [Show full text]
  • Hormone Testing Summary All Units Are Given in Ng/Mg Creatinine
    Accession # 00212403 Sample Female Report 123 A Street Sometown, CA 90266 Collection Times: Ordering physician: DOB:1976-01-01 2015-08-16 05:00PM 2015-08-16 10:00PM Precision Analytical Gender: Female 2015-08-17 06:00AM 2015-08-17 08:00AM Hormone Testing Summary All units are given in ng/mg creatinine Sex Hormones See Pages 2 and 3 for a thorough breakdown of sex hormone metabolites opausa n l R e a m n e r g P e your 27.0 62.0 6.0 4.0 14.0 low limit high limit 80.5 17.9 12.8 result Postmenopausal 20.0 range 6.0-17.0 0.3-2.0 Total Estrogen Progesterone Testosterone How to read the graphical (Sum of 8 Estrogen Metabolites) (Serum Equivalent, ng/mL) representation of results Progesterone Serum Equivalent is a calculated value based on urine pregnanediol. This value may not accurately reflect serum when progesterone is taken by mouth. Adrenal Hormones See pages 4 and 5 for a more complete breakdown of adrenal hormones Total DHEA Production 100 High Range Limit 400.0 2500.0 ) 2218.0 g Age Range m Daily Free Cortisol Pattern / g 20-40 800-2500 n 80 ( 40-60 530-1550 Total DHEA Production l >60 400-1350 (DHEAS + Etiocholanolone + Androsterone) o s 60 i t r o C 40 2240.0 4300.0 Patient Values Low Range Limit 80.0 48.0 180.0 5033.0 20 24hr Free Cortisol cortisol Metabolized Cortisol (THF+THE) 0 (A+B+C+D) metabolism (Total Cortisol Production) Waking (A) Morning (B) Afternoon (C) Night (D) Free cortisol best reflects tissue levels.
    [Show full text]
  • Androstenedione
    NTP TECHNICAL REPORT ON THE TOXICOLOGY ANd CARCINOGENESIS STUdIES OF ANdROSTENEdIONE (CAS NO. 63-05-8) IN F344/N RATS ANd B6C3F1 MICE (GAVAGE STUdIES) NATIONAL TOXICOLOGY PROGRAM P.O. Box 12233 Research Triangle Park, NC 27709 September 2010 NTP TR 560 NIH Publication No. 10-5901 National Institutes of Health Public Health Service U.S. dEPARTMENT OF HEALTH ANd HUMAN SERVICES FOREWORd The National Toxicology Program (NTP) is an interagency program within the Public Health Service (PHS) of the Department of Health and Human Services (HHS) and is headquartered at the National Institute of Environmental Health Sciences of the National Institutes of Health (NIEHS/NIH). Three agencies contribute resources to the program: NIEHS/NIH, the National Institute for Occupational Safety and Health of the Centers for Disease Control and Prevention (NIOSH/CDC), and the National Center for Toxicological Research of the Food and Drug Administration (NCTR/FDA). Established in 1978, the NTP is charged with coordinating toxicological testing activities, strengthening the science base in toxicology, developing and validating improved testing methods, and providing information about potentially toxic substances to health regulatory and research agencies, scientific and medical communities, and the public. The Technical Report series began in 1976 with carcinogenesis studies conducted by the National Cancer Institute. In 1981, this bioassay program was transferred to the NTP. The studies described in the Technical Report series are designed and conducted to characterize and evaluate the toxicologic potential, including carcinogenic activity, of selected substances in laboratory animals (usually two species, rats and mice). Substances selected for NTP toxicity and carcinogenicity studies are chosen primarily on the basis of human exposure, level of production, and chemical structure.
    [Show full text]
  • Metabolism of Testoterone and Related Steroids in Metastatic Interstitial Cell Carcinoma of the Testis
    Metabolism of testoterone and related steroids in metastatic interstitial cell carcinoma of the testis. M B Lipsett, … , C W Bardin, L M Fishman J Clin Invest. 1966;45(11):1700-1709. https://doi.org/10.1172/JCI105476. Research Article Find the latest version: https://jci.me/105476/pdf Journal of Clinical Investigation Vol. 45, No. 11, 1966 Metabolism of Testosterone and Related Steroids in Metastatic Interstitial Cell Carcinoma of the Testis * M. B. LIPSETT,t G. A. SARFATY, H. WILSON, C. WAYNE BARDIN, AND L. M. FISHMAN (From the Endocrinology Branch, National Cancer Institute, Bethesda, Md.) Interstitial cell carcinoma of the testis is a singu- production rate has been shown to be a conse- larly rare steroid-producing cancer. Of the seven quence of metabolism of dehydroepiandrosterone reported cases (1-7), urinary 17-ketosteroid (17- sulfate. KS) excretion was high in the four cases in which it was measured. Abelson, Bulaschenko, Trom- Methods mer, and Valdes-Dapena (7) fractionated the uri- Routine methods were used to analyze the following: nary 17-ketosteriods and corticoids in one recently urinary 17-KS (8), urinary 17-hydroxycorticoids (9), reported case. There is, however, no comprehen- plasma Silber-Porter chromogens (10), and plasma tes- tosterone (11). sive study of either the production of androgens Gas-liquid chromatography. We carried out gas-liquid or related steroids by this tumor. We have had chromatography (GLC) in a Glowell Chromolab gas the opportunity to study a patient with metastatic chromatograph utilizing a 'Sr ionization detector oper- interstitial cell carcinoma, and we have examined ating at 1,050 v.
    [Show full text]
  • Adult Subjects and Patients with Various Endocrine Disorders *
    Journal of Clinical Investigation Vol. 43, No. 6, 1964 Studies on the Origin of Testosterone in the Urine of Normal Adult Subjects and Patients with Various Endocrine Disorders * ALVRO M. CAMACHO t AND CLAUDE J. 'MIGEON (From the Endocrine Clinic of the Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Md.) We have recently described a procedure for the lized to testosterone glucuronide. In addition, the isolation of testosterone 1 from human urine after metabolism of testosterone and the quantity ex- P-glucuronidase hydrolysis, indicating that it was creted as unconjugated testosterone, as testosterone conjugated with glucuronic acid (1). We also glucuronide, and as testosterone sulfate was reported on the urinary excretion of testosterone studied. in adult subjects and in patients with endocrine Methods disorders. 1) Preparation of radioactive steroids. 4-C14-testos- The concentration of 17-ketosteroids in bio- terone 2 (SA, 71.43 /Ac per mg), 1,2-H3-testosterone (SA, logical fluids is commonly used as an index of 2.63 mc per mg), 4-C'4-17a-hydroxyprogesterone (SA, virilization. Frequently, however, there is no cor- 43.48 ,uc per mg), 4-C14-androstenedione (SA, 7.58 ,uc per relation between the degree of virilism observed mg), and 7a-H3-dehydroepiandrosterone acetate (SA, in patients and levels of the 17-ketosteroids in 25.65 mc per mg) were used in this investigation. Be- blood fore use, they were purified by paper chromatography or urine. Testosterone could be produced (2). by such patients in amounts sufficient to cause 2) Mode of injection of radioactive steroids and urine virilization without appreciably increasing the collections.
    [Show full text]
  • Analysis of Anabolic Steroid Glucuronide and Sulfate Conjugates
    Applicability of an innovative steroid-profiling method to determine synthetic growth promoter abuse in cattle Blokland, M.H.; Tricht, E.F. van; Ginkel L.A. van; Sterk, S.S. This is a "Post-Print" accepted manuscript, which has been published in “Catena” This version is distributed under a non-commencial no derivatives Creative Commons (CC-BY-NC-ND) user license, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and not used for commercial purposes. Further, the restriction applies that if you remix, transform, or build upon the material, you may not distribute the modified material. Please cite this publication as follows: Blokland, M.H.; Tricht, E.F. van; Ginkel L.A. van; Sterk, S.S. (2017) Applicability of an innovative steroid-profiling method to determine synthetic growth promoter abuse in cattle. The Journal of Steroid Biochemistry and Molecular Biology 174, p. 265-275 You can download the published version at: https://doi.org/10.1016/j.jsbmb.2017.10.007 Applicability of an innovative steroid-profiling method to determine synthetic growth promoter abuse in cattle 5 M.H. Blokland*, E.F. van Tricht, L.A van Ginkel, S.S. Sterk RIKILT Wageningen University & Research, P.O. Box 230, Wageningen, The Netherlands 10 *Corresponding author: M.H. Blokland, Tel.: +31 317 480417, E-mail: [email protected] 15 Keywords: synthetic steroids, growth promoters, cattle, UHPLC-MS/MS, steroid profiling, steroidogenesis Abstract 20 A robust LC-MS/MS method was developed to quantify a large number of phase I and phase II steroids in urine.
    [Show full text]
  • The Metabolism of Androstenone and Other Steroid Hormone Conjugates in Relation to Boar Taint
    The Metabolism of Androstenone and Other Steroid Hormone Conjugates in Relation to Boar Taint by Heidi M. Laderoute A Thesis presented to The University of Guelph In partial fulfillment of requirements for the degree of Master of Science in Animal and Poultry Science with Toxicology Guelph, Ontario, Canada © Heidi M. Laderoute, April, 2015 ABSTRACT THE METABOLISM OF ANDROSTENONE AND OTHER STEROID HORMONE CONJUGATES IN RELATION TO BOAR TAINT Heidi M. Laderoute Advisor: University of Guelph, 2015 Dr. E.J. Squires Increased public interest in the welfare of pigs reared for pork production has led to an increased effort in finding new approaches for controlling the unpleasant odour and flavour from heated pork products known as boar taint. Therefore, this study investigated the metabolism of androstenone and the enzymes involved in its sulfoconjugation in order to further understand the pathways and genes involved in the development of this meat quality defect. Leydig cells that were incubated with androstenone produced 3-keto- sulfoxy-androstenone, providing direct evidence, for the first time, that sulfoconjugation of this steroid does occur in the boar. In addition, human embryonic kidney cells that were overexpressed with porcine sulfotransferase (SULT) enzymes showed that SULT2A1, but not SULT2B1, was responsible for sulfoconjugating androstenone. These findings emphasize the importance of conjugation in steroid metabolism and its relevance to boar taint is discussed. ACKNOWLEDGEMENTS I would like to gratefully and sincerely thank my advisor, Dr. E. James Squires, for providing me with the opportunity to be a graduate student and for introducing me to the world of boar taint. This project would not have been possible without your guidance, encouragement, and patience over the last few years.
    [Show full text]
  • Disposition and Metabolic Profile of the Weak Androgen
    APPLIED MEDICINE: CLINICAL PATHOLOGY AND DERMATOLOGY Disposition and Metabolic Profile of the Weak Androgen Dehydroepiandrosterone After Administration as Part of a Nutritional Supplement to Exercised Horses Rick M. Arthur, DVM†; Heather K. Knych, DVM, PhD, Diplomate ACVCP*; and Scott D. Stanley, PhD After oral administration of a nutritional supplement containing dehydroepiandrosterone (DHEA), horses are capable of producing detectable levels of testosterone, which can result in a positive regulatory finding. Authors’ addresses: School of Veterinary Medicine (Arthur), K.L. Maddy Equine Analytical Chemistry Laboratory (Knych, Stanley), University of California, Davis, CA 95616; e-mail: [email protected]. *Corresponding author; †presenting author. © 2013 AAEP. 1. Introduction various times up to 48 hours after drug administra- Dehydroepiandrosterone (DHEA) is a weak andro- tion. Plasma concentrations of DHEA, testoster- gen as well as a precursor to the much more potent one, and pregnenolone as well as their sulfated androgen, testosterone. Although DHEA is not conjugates were measured by means of liquid chro- specifically banned from administration to race- matography-mass spectrometry. horses, the potential for metabolism to substances such as testosterone that are not permitted in racing 3. Results and Discussion make its presence in nutritional supplements fed to Peak plasma concentrations of DHEA, DHEA sul- horses a regulatory concern. In the current study, fate, and testosterone sulfate were 10.1 Ϯ 8.84 ng/ we sought to describe the metabolic profile after Ϯ Ϯ administration of a nutritional supplement contain- ml, 25.7 10.2, and 0.670 1.17, respectively. ing precursors to non-permitted androgens to exer- All compounds were below the limit of detection by cised female horses.
    [Show full text]
  • Sports Drug Testing and Toxicology TOP ARTICLES SUPPLEMENT
    Powered by Sports drug testing and toxicology TOP ARTICLES SUPPLEMENT CONTENTS REVIEW: Applications and challenges in using LC–MS/MS assays for quantitative doping analysis Bioanalysis Vol. 8 Issue 12 REVIEW: Current status and recent advantages in derivatization procedures in human doping control Bioanalysis Vol. 7 Issue 19 REVIEW: Advances in the detection of designer steroids in anti-doping Bioanalysis Vol. 6 Issue 6 Review For reprint orders, please contact [email protected] 8 Review 2016/05/28 Applications and challenges in using LC–MS/MS assays for quantitative doping analysis Bioanalysis LC–MS/MS is useful for qualitative and quantitative analysis of ‘doped’ biological Zhanliang Wang‡,1, samples from athletes. LC–MS/MS-based assays at low-mass resolution allow fast Jianghai Lu*,‡,2, and sensitive screening and quantification of targeted analytes that are based on Yinong Zhang1, Ye Tian2, 2 ,2 preselected diagnostic precursor–product ion pairs. Whereas LC coupled with high- Hong Yuan & Youxuan Xu** 1Food & Drug Anti-doping Laboratory, resolution/high-accuracy MS can be used for identification and quantification, both China Anti-Doping Agency, 1st Anding have advantages and challenges for routine analysis. Here, we review the literature Road, ChaoYang District, Beijing 100029, regarding various quantification methods for measuring prohibited substances in PR China athletes as they pertain to World Anti-Doping Agency regulations. 2National Anti-doping Laboratory, China Anti-Doping Agency, 1st Anding Road, First draft submitted:
    [Show full text]